Transcriptional Regulation of BACE1 by NFAT3 Leads to Enhanced Amyloidogenic Processing

Neurochemical Research

Volumn 40, Issue 4, 2015, Pages 829-836

  Mei, Zhengrong ^a   Yan, Pengke ^a   Tan, Xiangping ^a   Zheng, Shiming ^a   Situ, Bing ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer s disease; Amyloid protein (A ); NFAT3; Site APP cleaving enzyme 1 (BACE 1)

Indexed keywords

AMYLOID; ASPARTIC PROTEINASE; BACE1 PROTEIN, MOUSE; SECRETASE; TRANSCRIPTION FACTOR NFAT;

ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; MALE; METABOLISM; MOUSE; PHYSIOLOGY; PROMOTER REGION;

AMYLOID; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; NFATC TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 84939970733     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-015-1533-1     Document Type: Article

References (30)

1. Cole SL, Vassar R (2008) The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology. J Biol Chem 283:29621–29625
2. Fukumoto H, Cheung BS, Hyman BT, Irizarry MC (2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59:1381–1389
3. Lee EB, Zhang B, Liu K, Greenbaum EA, Doms RW, Trojanowski JQ, Lee VM (2005) BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo. J Cell Biol 168:291–302
4. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 4:233–234
5. Wen Y, Onyewuchi O, Yang S, Liu R, Simpkins JW (2004) Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res 1009:1–8
6. Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, Staufenbiel M, Huang LE, Song W (2006) Hypoxia facilitates Alzheimer’s disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci USA 103:18727–18732
7. Sutinen EM, Pirttilä T, Anderson G, Salminen A, Ojala JO (2012) Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells. J Neuroinflamm 9:199
8. Guglielmotto M, Aragno M, Autelli R, Giliberto L, Novo E, Colombatto S, Danni O, Parola M, Smith MA, Perry G, Tamagno E, Tabaton M (2009) The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha. J Neurochem 108:1045–1056
9. Ge YW, Maloney B, Sambamurti K, Lahiri DK (2004) Functional characterization of the 5′ flanking region of the BACE gene: identification of a 91 bp fragment involved in basal level of BACE promoter expression. Faseb J 18:1037–1039
10. Oh-hora M, Rao A (2008) Calcium signaling in lymphocytes. Curr Opin Immunol 20:250–258
11. Fric J, Zelante T, Wong AY, Mertes A, Yu HB, Ricciardi-Castagnoli P (2012) NFAT control of innate immunity. Blood 120:1380–1389
12. Abdul HM, Sama MA, Furman JL, Mathis DM, Beckett TL, Weidner AM, Patel ES, Baig I, Murphy MP, LeVine H 3rd, Kraner S, Norris CM (2009) Cognitive decline in Alzheimer’s disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci 29:12957–12969
13. Ansaloni S, Leung B, Dubey A, Saunders A (2012) Tyrosine kinase receptor B isoforms alter APP and BACE1 endogenous levels independently of BDNF. Adv Alzheimer’s Dis 1:93–101
14. Shi C, Zheng DD, Fang L, Wu F, Kwong WH, Xu J (2012) Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt. Biochim Biophys Acta 1820:453–460
15. Kim HG, Moon M, Choi JG, Park G, Kim AJ, Hur J, Lee KT, Oh MS (2014) Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo. Neurotoxicology 40:23–32
16. Huang C, Lin Y, Su H, Ye D (2015) Forsythiaside Protects Against Hydrogen Peroxide-Induced Oxidative Stress and Apoptosis in PC12 Cell. Neurochem Res 40:27–35
17. Mei Z, Situ B, Tan X, Zheng S, Zhang F, Yan P, Liu P (2010) Cryptotanshinione upregulates alpha-secretase by activation PI3K pathway in cortical neurons. Brain Res 1348:165–173
18. Ueberham U, Hilbrich I, Ueberham E, Rohn S, Glockner P, Dietrich K, Bruckner MK, Arendt T (2012) Transcriptional control of cell cycle-dependent kinase 4 by Smad proteins-implications for Alzheimer’s disease. Neurobiol Aging 33:2827–2840
19. Christensen MA, Zhou W, Qing H, Lehman A, Philipsen S, Song W (2004) Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. Mol Cell Biol 24:865–874
20. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356
21. Rossner S, Sastre M, Bourne K, Lichtenthaler SF (2006) Transcriptional and translational regulation of BACE1 expression–implications for Alzheimer’s disease. Prog Neurobiol 79:95–111
22. Wen Y, Yu WH, Maloney B, Bailey J, Ma J, Marié I, Maurin T, Wang L, Figueroa H, Herman M, Krishnamurthy P, Liu L, Planel E, Lau LF, Lahiri DK, Duff K (2008) Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron 57:680–690
23. Chen CH, Zhou W, Liu S, Deng Y, Cai F, Tone M, Tone Y, Tong Y, Song W (2012) Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer’s disease. Int J Neuropsychopharmacol 15:77–90
24. Cho HJ, Jin SM, Youn HD, Huh K, Mook-Jung I (2008) Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling. Aging Cell 7:137–147
25. Cole SL, Vassar R (2008) The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology. J Biol Chem 44:29621–29625
26. Ghosh AK, Osswald HL (2014) BACE1 (β-secretase) inhibitors for the treatment of Alzheimer’s disease. Chem Soc Rev 19:6765–6813
27. LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer’s disease. Nat Rev Neurosci 11:862–872
28. Reese LC, Taglialatela G (2011) A role for calcineurin in Alzheimer’s disease. Curr Neuropharmacol 9:685–692
29. Abdul HM, Furman JL, Sama MA, Mathis DM, Norris CM (2010) NFATs and Alzheimer’s Disease. Mol Cell Pharmacol 2:7–14
30. Thibault O, Gant JC, Landfield PW (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer’s disease: minding the store. Aging Cell 6:307–317